innovative approaches to investigating kras therapeutics with biochemical and cell based assays 2
Published 1 year ago • 301 plays • Length 31:44Download video MP4
Download video MP3
Similar videos
-
54:30
endpoint assays for the characterization of rare and therapy resistant cells in cancer
-
0:35
data on kras inhibitors in lung cancer at wclc 2022
-
20:43
using cell based assays in the development of efficacious cancer therapies.
-
36:53
covid-19 serology assays and cell therapy strategies
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer
-
8:47
innovations within precision oncology: evolution of a biomarker—a case study of kras g12c
-
31:53
combined inhibition of the ras pathway and autophagy as a treatment approach for pancreatic cancer
-
1:09
challenges in targeting krasg12c mutations
-
1:09:59
george poste - the need for critical reassessment of current strategies for cancer therapeutics
-
38:04
blood-based detection: egfr/ kras mutations for nsclc patients using multiplexed droplet digital pcr
-
40:07
profiling the cell surface of cancer cell lines for biomarker/drug target discovery
-
59:47
in vitro screening approaches to estimate human hepatic responses to xenobiotic exposures
-
1:44
sureselect cancer cgp assay and workflow overview
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
2:58
multiplex digital pcr panels for ultrasensitive & specific detection of actionable kras & egfr
-
21:13
the kras variant and cancer risk
-
1:04:37
ngs for precision oncology in solid tumors: from research to clinical practice
-
20:44
identifying tumour suppressors that interact with oncogenic kras in intrahepatic cca
-
1:59
phase i a study evaluating gdc-6036 monotherapy in patients with nsclc with kras g12c mutation